These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11896464)

  • 21. Targeting an adenoviral gene vector to cytokine-activated vascular endothelium via E-selectin.
    Harari OA; Wickham TJ; Stocker CJ; Kovesdi I; Segal DM; Huehns TY; Sarraf C; Haskard DO
    Gene Ther; 1999 May; 6(5):801-7. PubMed ID: 10505104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene transfer in ovarian cancer cells: a comparison between retroviral and lentiviral vectors.
    Indraccolo S; Habeler W; Tisato V; Stievano L; Piovan E; Tosello V; Esposito G; Wagner R; Uberla K; Chieco-Bianchi L; Amadori A
    Cancer Res; 2002 Nov; 62(21):6099-107. PubMed ID: 12414634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intratumoral gene delivery of anti-cathepsin L single-chain variable fragment by lentiviral vector inhibits tumor progression induced by human melanoma cells.
    Frade R; Rousselet N; Jean D
    Cancer Gene Ther; 2008 Sep; 15(9):591-604. PubMed ID: 18617916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel adenoviral gene delivery system targeted against head and neck cancer.
    Li D; Guang W; Abuzeid WM; Roy S; Gao GP; Sauk JJ; O'Malley BW
    Laryngoscope; 2008 Apr; 118(4):650-8. PubMed ID: 18176343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new human antitumor immunoreagent specific for ErbB2.
    De Lorenzo C; Palmer DB; Piccoli R; Ritter MA; D'Alessio G
    Clin Cancer Res; 2002 Jun; 8(6):1710-9. PubMed ID: 12060608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A functional role for CD28 costimulation in tumor recognition by single-chain receptor-modified T cells.
    Moeller M; Haynes NM; Trapani JA; Teng MW; Jackson JT; Tanner JE; Cerutti L; Jane SM; Kershaw MH; Smyth MJ; Darcy PK
    Cancer Gene Ther; 2004 May; 11(5):371-9. PubMed ID: 15060573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetically targeted T cells eradicate established breast cancer in syngeneic mice.
    Wang H; Wei H; Zhang R; Hou S; Li B; Qian W; Zhang D; Kou G; Dai J; Guo Y
    Clin Cancer Res; 2009 Feb; 15(3):943-50. PubMed ID: 19188165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction, expression and characterization of the engineered antibody against tumor surface antigen, p185(c-erbB-2).
    Cheng LS; Liu AP; Yang JH; Dong YQ; Li LW; Wang J; Wang CC; Liu J
    Cell Res; 2003 Feb; 13(1):35-48. PubMed ID: 12643348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth inhibition efficacy of an adenovirus expressing dual therapeutic genes, wild-type p53, and anti-erbB2 ribozyme, against human bladder cancer cells.
    Irie A; Matsumoto K; Anderegg B; Kuruma H; Kashani-Sabet M; Scanlon KJ; Uchida T; Baba S
    Cancer Gene Ther; 2006 Mar; 13(3):298-305. PubMed ID: 16110311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
    Akbulut H; Zhang L; Tang Y; Deisseroth A
    Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene therapy using adenovirus-mediated full-length anti-HER-2 antibody for HER-2 overexpression cancers.
    Jiang M; Shi W; Zhang Q; Wang X; Guo M; Cui Z; Su C; Yang Q; Li Y; Sham J; Liu X; Wu M; Qian Q
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6179-85. PubMed ID: 17062695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined effects of tamoxifen and a chimeric humanized single chain antibody against the type I IGF receptor on breast tumor growth in vivo.
    Ye JJ; Liang SJ; Guo N; Li SL; Wu AM; Giannini S; Sachdev D; Yee D; Brünner N; Ikle D; Fujita-Yamaguchi Y
    Horm Metab Res; 2003; 35(11-12):836-42. PubMed ID: 14710366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene.
    Yu W; Pirollo KF; Rait A; Yu B; Xiang LM; Huang WQ; Zhou Q; Ertem G; Chang EH
    Gene Ther; 2004 Oct; 11(19):1434-40. PubMed ID: 15229629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced apoptosis following treatment with TRA-8 anti-human DR5 monoclonal antibody and overexpression of exogenous Bax in human glioma cells.
    Kaliberov S; Stackhouse MA; Kaliberova L; Zhou T; Buchsbaum DJ
    Gene Ther; 2004 Apr; 11(8):658-67. PubMed ID: 14973547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viral vector-mediated transduction of a modified thrombospondin-2 cDNA inhibits tumor growth and angiogenesis.
    Hahn W; Ho SH; Jeong JG; Hahn EY; Kim S; Yu SS; Kim S; Kim JM
    Gene Ther; 2004 May; 11(9):739-45. PubMed ID: 15103317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracellular antibody against erbB-2 mediates targeted tumor cell eradication by apoptosis.
    Deshane J; Grim J; Loechel S; Siegal GP; Alvarez RD; Curiel DT
    Cancer Gene Ther; 1996; 3(2):89-98. PubMed ID: 8729907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cox-2 promoter-based replication-selective adenoviral vector to target the cox-2-expressing human bladder cancer cells.
    Shirakawa T; Hamada K; Zhang Z; Okada H; Tagawa M; Kamidono S; Kawabata M; Gotoh A
    Clin Cancer Res; 2004 Jul; 10(13):4342-8. PubMed ID: 15240520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer gene therapy using a novel secretable trimeric TRAIL.
    Kim CY; Jeong M; Mushiake H; Kim BM; Kim WB; Ko JP; Kim MH; Kim M; Kim TH; Robbins PD; Billiar TR; Seol DW
    Gene Ther; 2006 Feb; 13(4):330-8. PubMed ID: 16195699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel approach using transcomplementing adenoviral vectors for gene therapy of adrenocortical cancer.
    Wolkersdörfer GW; Bornstein SR; Higginbotham JN; Hiroi N; Vaquero JJ; Green MV; Blaese RM; Aguilera G; Chrousos GP; Ramsey WJ
    Horm Metab Res; 2002 Jun; 34(6):279-87. PubMed ID: 12173067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.